• 제목/요약/키워드: Aortic Valve, replacement

검색결과 411건 처리시간 0.034초

95세 환자에게 응급으로 시행한 대동맥 판막 치환술 (Emergency Aortic Valve Replacement for a 95-year-old Patient)

  • 장원호;염욱;한정욱;오홍철;현민수;김현조
    • Journal of Chest Surgery
    • /
    • 제42권3호
    • /
    • pp.368-370
    • /
    • 2009
  • 전체 인구 연령이 증가함에 따라 심장수술을 시행 받는 고령의 환자들이 많아지고 있다. 80세 이상의 고령의 환자들에게서 시행한 대동맥 판막 치환술이 훌륭한 결과와 좋은 만기 생존율을 보이고 있지만, 몇몇 내과의사들은 고령의 환자들에게 수술적 치료를 고려하는 것을 주저하고 있다. 95세 여자 환자가 심인성 쇼크를 주소로 내원하였고 응급 수술이 필요한 상태였으며 응급으로 대동맥 판막 치환술을 성공적으로 시행 받았다. 95세의 고령환자에게 성공적으로 응급 대동맥 판막 치환술을 시행 하였기에 이를 보고하는 바이다.

혈관손상에 관한 임상적 고찰 (Surgical Treatment of Vascular Injuries)

  • 홍종완
    • Journal of Chest Surgery
    • /
    • 제21권6호
    • /
    • pp.984-989
    • /
    • 1988
  • 2-D echocardiographic examination of the aortic root diameter was known to be useful in the selection of the size of the prosthetic valve. Valve-patient mismatch was occasionally a serious problem after valve replacement, especially in aortic valve disease. Preoperative knowledge of the patient`s valve annulus size is therefore of great importance in the surgical management of these patients. So the relationship between preoperative 2-D echocardiographic diameter of the annulus size and replaced prosthetic valve were evaluated. 13 patients were analyzed in this study. 2-D echocardiographic measurements of aortic annulus diameter, as determined from the parasternal long axis view and apical four chamber view, demonstrated a high correlation with actual prosthetic valve size implanted at surgery[r=0.86, p< 0.001, SEE=1.08].

  • PDF

대동맥관 폐쇄부전을 동반한 상행대동맥의 외과적 치료 (Results with Total Replacement of the Ascending Aorta and Reimplantation of the Coronary Arteries)

  • 안혁;노준량
    • Journal of Chest Surgery
    • /
    • 제24권4호
    • /
    • pp.352-356
    • /
    • 1991
  • From April, 1981, to April, 1990, 20 male and 7 female patients ranging in age from 17 to 63, were operated on for aortic insufficiency with an aneurysm of the ascending aorta. Ten patients were in New York Heart Association functional class II, 7 in class III, and ten in class IV. The surgical treatment in all cases consisted of total replacement of the ascending aorta with composite graft containing a prosthetic aortic valve and reimplantation of the coronary arteries by an intermediate tube graft. In 15 patients an uncomplicated annulo-aortic ectasia existed, and in 12 an aortic dissection; three of the latter group were operated during the acute phase. 17 patients showed typical Marfan syndrome, and 3 patients showed severe ascending aortic aneurysm secondary to the aortic valve disease. The overall operative mortality was 7%[2 deaths]. Those 2 deaths occurred following emergency operation due to associated aortic dissection, but no death during elective operation. All survivors have been followed-up during a period ranging 1 to 108 month[average 34 months]. There was no late mortality. Among the survivors, clinical improvement is readily apparent[2,3 in class I, 2 in class II ]. In conclusion, the treatment of aortic insufficiency associated with an aneurysm of the ascending aorta by insertion of a composite graft and reimplantation of the coronary arteries through an intermediate Dacron tube is a reliable method with low mortality and excellent results.

  • PDF

Incidence of and Risk Factors for the Development of Significant Tricuspid Regurgitation after Isolated Aortic Valve Replacement

  • Minsang Kang;Jae Woong Choi;Suk Ho Sohn;Ho Young Hwang;Kyung Hwan Kim
    • Journal of Chest Surgery
    • /
    • 제56권5호
    • /
    • pp.304-310
    • /
    • 2023
  • Background: The late progression of tricuspid regurgitation (TR) after mitral valve surgery is well known. However, few reports have described the progression of TR after aortic valve surgery. We investigated the incidence of and risk factors for the development of significant TR after isolated aortic valve replacement (AVR). Methods: This study analyzed patients with less than moderate TR who underwent isolated AVR at Seoul National University Hospital from January 1990 to December 2018. Significant TR was defined as moderate or higher. Echocardiographic follow-up was performed in all patients. The Fine-Gray model was used to identify clinical risk factors for the development of significant TR. Results: In total, 583 patients (61.7±14.2 years old) were included. Operative mortality occurred in 9 patients (1.5%), and the overall survival rates at 10, 20, and 25 years were 91.1%, 83.2%, and 78.9%, respectively. Sixteen patients (2.7%) developed significant TR during the follow-up period (13 moderate; 3 severe). The cumulative incidence of significant TR at 10, 20, and 25 years was 0.77%, 3.83%, and 6.42%, respectively. No patients underwent reoperation or reintervention of the tricuspid valve. Hemodialysis or peritoneal dialysis for chronic kidney disease (hazard ratio [HR], 5.188; 95% confidence interval [CI], 1.154-23.322) and preoperative mild TR (HR, 5.919; 95% CI, 2.059-17.017) were associated with the development of significant TR in the multivariable analysis. Conclusion: TR progression after isolated AVR in patients with less than moderate TR is rare. Preoperative mild TR and hemodialysis or peritoneal dialysis for chronic kidney disease were significant risk factors for the development of TR.

협소 대동맥 판륜을 가진 환자에서의 대동맥치환술시 판륜 확장술의 중기 성적 (Midterm results of aortic root enlargement with AVR in patients with narrow aortic root and AS)

  • 박광훈;김하늘루;최강주;이양행;황윤호;조광현
    • Journal of Chest Surgery
    • /
    • 제33권4호
    • /
    • pp.285-289
    • /
    • 2000
  • Background: For AVR using conventional prosthetic valves in adult patients with a narrow aortic root, aortic root enlargement is necessary to reduce postoperative pressure gradient across the aortic valve (ΔP). An evaluation of early and mid-term results of aortic root enlargement with AVR and echocardiographic follow up of ΔP and left ventricular function was performed. Method: From Aug. 1991 to Feb. 1998, eighteen patients aged 17 to 59 years(mean, 38$\pm$12 years) underwent Manouguian procedure with AVR. Aortic annular circumstance was enlarged 10.0mm to 18.0mm(mean, 12.6$\pm$6.3mm). Eight patients(44.0%) had NYHA class III status before operation, and seven cases of them underwent concomitant MVR. Valve pathology was ASr in 6 cases, AS in 4 cases, nd ASr+MSr in 8 cases. Replaced valve size was 21mm in 8 cases and 23 mm in 10 cases, and St. Jude Medical mechanical valve was used in 10 cases and Carbomedics in 8 cases. Result: Follow-up duration was 6 to 57 months (mean, 26$\pm$18 months), and total follow-up was 287 patient-year. There were one hospital death and one late death, therefore, actuarial survival rate was 85.7% at 56 months. Peak ΔP wad decreased significantly at postoperative mid-term period as 13$\pm$5mmHg, compared with thepreoperative one (42$\pm$8mmHg) (p<0.01). LVM(gm/$m^2$) was also diminished as 35.8%(115$\pm$36gm/$m^2$)at postoperative mid-term period, compared with preoperative one (179$\pm$56gm/$m^2$)(p<0.05). Conclusion: There were no specific complications related to the procedure. And we could have adequate enlargement of aortic annulus to suitable prosthetic valve that have no effect of patient-prosthese mismatch.

  • PDF

대동맥판역류증과 좌심실수축말기용적 확장이 있는 환자에서 좌심실최고수축기압/수축말기용적비와 판막치환후의 증상적 호전과의 관계 (Correlation Between Left Ventricular Peak Systolic Pressure/End-Systolic Volume Ratio and Symptomatic Improvement with Valve Replacement in Patients with Aortic Regurgitation and Enlarged End-Systolic Volume)

  • 김웅한;안혁
    • Journal of Chest Surgery
    • /
    • 제29권8호
    • /
    • pp.867-874
    • /
    • 1996
  • 이 연구는 대동맥판역류증이 있으면서 좌심실수축말기용적(left ventricular end-systolic volullle)이 커져있는 환자에서 수술전 좌심실 최고수축기압수축말기용적비(left ventricular peak systolic presslle/end-systolic volume ratio)를 판막치환후의 증상적 호전 판단의 자료로서의 적용 여부를 검토하기위한 것이 다 대상은 중정도 이상의 대돈맥판역류증이 있고다른 심혈관계의 이상이 없으면서 좌심실수축말기용적이 60mm2 넘는 21명(남 15, 여 6, 15까에서 60세가지 연령 분포)이었다. 이들을 대상으로 심도자시 통 상적으로 측정하는 여러 변수와 판막치환후 증상적 호전과의 관계에 대해서 분석하였다. 수술 6개월후 증세의 호전이 13명(62%)의 환자에서 있었고, 8명(38%)에서는 증세의 변화가 없었다. 복합변수분석을 통해서 좌심실최고수축기압$\boxUl$수축말기 용적 비는 통계적으로 유의하게 수술 a개월후의 기능적분류상태(p=0.005)와 수술전에 비해 수술 6개월후 기능적분류상태의 변화 정도(p=0.032)를 판단 하는 지표임을 나타냈었다. 판막치환 6개월후 비가 1.71 mmHg/ml/m2 이상되는 모든 환자는 기능상태 I 혹은 II를 유지한 반면 비가 1.71 mmHg ml/m2 미만인 환자에서는 40%가 기능적분류상태 III이 있다. 좌심실 수축말기 용적이 60 ml/m2 이상 커져 있는 대동맥 판역류증 환자에서 좌심실최고수축기 압1수축 말기용적비는 판막치환후의 증상적 호전을 예측하는 지표로 사용될 수 있다.

  • PDF

개심술 치험 보고: 12예 (Clinical experience of open heart surgery: 12 cases)

  • 최영호
    • Journal of Chest Surgery
    • /
    • 제16권3호
    • /
    • pp.289-294
    • /
    • 1983
  • The report is concerned to our experience of 12 cases of open heart surgery under the extracorporeal circulation at the Department of Thoracic and Cardiovascular Surgery, Chosun University Hospital during the period between Nov, 1979 and April, 1983. 1. There were 4 cases of congenital anomaly and 8 cases of acquired heart disease. 2. There were 6 male and 6 female patients with a mean age of 20 years. [range 9 to 33 years]. 3. The cases induced 2 ventricular septal defect, 2 atrial septal defects and 8 acquired valvular heart diseases. 4. The surgical managements were 2 primary repair for atrial septal defect and 2 patch closure for ventricular septal defect, 1 triple valve replacement [AVR MVR TVR], 1 aortic valve replacement, 4 double valve replacement [AVR MVR] and 2 open mitral commissurotomy for pure mitral stenosis. 5. The average cardiopulmonary bypass time was 61.5 minutes for congenital heart disease and 201.4 minutes for acquired valvular heart disease and the average aortic cross clamping time was 36.75 minutes for the former and 165.6 minutes for the latter. 6. Postoperatively, there were 1 Alopecia, 1 Electric burn and 1 wound infection as complication. 7. Overall operative mortality was 8.3%. 7. All patients received valve replacement were recommended anticoagulation with persantin.

  • PDF

CarboMEdics 기계판막을 이용한 심장판막 치환술의 임상 연구 (Clinical Study of Prosthetic Heart Valve Replacement with CarboMedics.)

  • 장원기;구자홍;조중구;김공수
    • Journal of Chest Surgery
    • /
    • 제33권1호
    • /
    • pp.45-50
    • /
    • 2000
  • Background: The CarboMedics prosthetic heart valve was produced in an attempt to improve the existing valve designs and was especially concerned with easily the implantation and further reduction of turbulence. Precise positioning of the valve in situ was achieved by the abilityof the valve to rotate relative to the sewing ring. Improved monitoring is possible due to increased radiopacity and the dacron sewing ring is coated with carbon to reduce pannus overgrowth. The leaflets have an opening angle of 78 degrees that apparently allows a rapid synchronous closure The aim of this study was to analyze the clinical performance of the CarboMedics valve prostheses(45 mitral 13 aortic and 7 double aortic-mitral valve replacement) were implanted in 65 patients(mean age 48.75$\pm$9.74 years) Result: The operative mortality was 3.1%(2/65) causes of death were low cardiac output syndrome. Total follow up was 1831 patient-months and mean follow up was 29.06$\pm$10.97 months/patient. No structural failure hemorrhage valve thrombosis and late death have been observed. Embolism occurred at a rate of 0.65%/Patient-year. Actuarial survival and thrombo-mbolism free rate at 36 months were 96.9% and 98.4% respectively. Consclusions: The CarboMedics valve stands for low valve related complicatons.

  • PDF

심근보호에 대한 임상적 고찰 (Clinical study of myocardial preservation)

  • 조재일;이영균
    • Journal of Chest Surgery
    • /
    • 제17권4호
    • /
    • pp.557-564
    • /
    • 1984
  • Of the valve replacement patients operated between 1983 and June, 1984, 75 patients need more than 60 minutes of aortic cross-clamping time. 42 patients performed single valve replacement [35 MVR, 7 AVR with or without TAP] and remainder needs double valve replacement with or without TAP. The average aortic clamping time was 95.1 minutes. They need 30 minutes more extra-corporeal circulation time than aortic clamping time. The patients were divided into two groups by usage of cardioplegic solution. Group I [n=31] with Bretschneider solution and group II with potassium cardioplegic solution [M.G.H. modification] were analyzed by extra-corporeal circulation data,/CG and Echocardiography findings, and clinical data. There was no difference between two groups in Bivon addition amounts [cc/kg] and E.F. and S.F. by echocardiography, group I need 1 more electrocardioversion to convert sinus rhythm postoperatively. Also no difference could be found in patients whose preoperative C.I. was above 2.0 between two group. But significant postoperative decrease in E.F. was found in group I whose preoperative C.I. was below 2.0. Relatively longer ECC time was also needed in same group. Ischemic changes in ECG and low cardiac output syndrome was, however more prevalent in groupII. As a whole, the clinical data was satisfactory with both cardioplegic solution in clinical practice.

  • PDF